Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Recruiting · NCT06482554 · Registry updated 2024-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. | Lethargy, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, nervous system disorder, psychiatric disorder, schizophrenia | Recruiting | Phase 3 | 2024-07-01 | NCT06482554 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Louisiana State University Health Sciences Center Shreveport | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| LSU Health Shreveport | Shreveport | United States | 1 |